As US FDA Shutdown Continues, What Will Be The Cost Of Not Spending?
Executive Summary
Bolus of applications could be filed once government reopens, but employee morale and recruitment efforts could suffer drop-off.
You may also be interested in...
US FDA Shuttering More Operations As User Fee Money Dwindles
Compounding carryover money runs out, crippling some activities although inspections will continue; countdown to the end of PDUFA fee balance continues.
Shutdown Week Four: FDA Maintains Pre-Shutdown Output Pace In Some Cases
ANDA and NDA/BLA supplement approvals continue thanks to carryover user fee funds, but US FDA hasn't made any NDA and BLA approvals during shutdown as as anxiety over effect of "lapse period" on agency increases.
Shutdown Week Three: Sponsors With Upcoming User Fee Dates Should Start Sweating
US FDA has enough carryover funding for another month of operations, Commissioner Gottlieb says, potentially endangering late February and March review goals.